Abstract

Mitral valve disease is a growing clinical problem. Surgical mitral valve repair and replacement remains the treatment of choice with excellent long-term clinical outcomes. However, a large number of symptomatic patients were deemed too high-risk undergoing surgical correction. Catheter-based technology has been in development to address this unmet need. Transcatheter mitral valve replacement devices are such technology and are currently undergoing clinical investigation. A systematic overview is being presented in the article.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call